Cindy Tahl, General Counsel and Secretary at FATE THERAPEUTICS INC (FATE), sold 139,002 shares at $51.15 ($7.0M) on 2020-11-05, disclosed to the SEC on 2020-11-06.
Open-market sale of $7.0M FATE by General Counsel and Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.41 | 51,519 | $2.6M | 37.0% |
| 2 | $50.41 | 51,519 | $2.6M | 37.0% |
| 3 | $50.55 | 16,682 | $843K | 12.0% |
| 4 | $50.55 | 16,682 | $843K | 12.0% |
| 5 | $51.15 | 2,600 | $133K | 1.9% |
| Total | $50.46 avg | 139,002 |
| $7.0M |
| 100% |
| Filing → |
| FATE | SELL | 2026-01-12 | $11K | — | Filing → |
| FATE | SELL | 2025-08-05 | $10K | — | Filing → |
| FATE | SELL | 2025-01-13 | $9K | — | Filing → |